August 24, 2016 7:29 PM ET

Biotechnology

Company Overview of BioCryst Pharmaceuticals, Inc.

Executive Profile

Nancy June Hutson Ph.D.

Director, Chairman of Corporate Governance & Nominating Committee, Member of Scientific Committee and Member of Compensation Committee, BioCryst Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships
67$165,022

Background

Dr. Nancy June Hutson, Ph.D., serves as the Chair of the Groton New London Laboratories Leadership Team and the Exploratory Development Strategy Team. Dr. Hutson has been an Independent Director of Endo International plc since February 28, 2014. She has been a Director of BioCryst Pharmaceuticals, Inc. since January 20, 2012 and Inspire Pharmaceuticals, Inc. since October 27, 2006. She has been a Director of Endo Pharmaceuticals Solutions Inc. since March 30, 2009. She ...

Corporate Headquarters

4505 Emperor Boulevard
Durham, North Carolina 27703

United States

Phone: 919-859-1302
Fax: 919-859-1314

Board Members Memberships

Trustee
Director
2006-Present
Director, Chairperson of Development Committee and Member of Compensation Committee
2009-Present
Director, Member of Compensation Committee and Member of Transactions Committee
2012-Present
Director, Chairman of Corporate Governance & Nominating Committee, Member of Scientific Committee and Member of Compensation Committee
2014-Present
Independent Director, Chairman of Operations Committee and Member of Nominating & Governance Committee

Education

PhD
Vanderbilt University
Post-Doctoral Training
Vanderbilt University
BA
Illinois Wesleyan University
Post-Doctoral Training
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$47,833
Total Calculated Compensation$165,022
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Sijmen de Vries M.D., MBAChairman of Management Board and Chief Executive Officer
Pharming Group NV
$626.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$3.3M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director, Director and Chairman of Executive Committee
Shire plc
$4.3M
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
$140.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioCryst Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.